State-licensed cannabis businesses pushing to ban hemp-derived THC products are making a strategic mistake that could undermine decades of drug policy reform, according to two veterans of the legalization movement.
Aaron Smith of Third Rail Advisory and Chris Lindsey, both former executives at the Marijuana Policy Project, argue that licensed operators who spent years claiming cannabis is safe can't now credibly argue it's dangerous when sold outside dispensaries. "If the industry we created now argues that THC is safe in a dispensary but dangerous in a liquor store, voters and policymakers will reasonably conclude we were never serious," Smith wrote.
The criticism comes as state-licensed cannabis businesses in multiple states have lobbied for bans on hemp-derived products like delta-8 THC and THCA flower. These products, which emerged from a loophole in the 2018 Farm Bill's hemp legalization, are sold in gas stations, smoke shops, and online—often at lower prices than dispensary products.
The Credibility Problem
Smith and Lindsey's argument cuts to the heart of cannabis policy reform. For years, advocates built public support for legalization by emphasizing that cannabis is safer than alcohol and that prohibition causes more harm than the substance itself. Licensed businesses benefited directly from that messaging.
But now some of those same businesses are backing state efforts to criminalize hemp products by claiming they're unsafe or unregulated. Smith and Lindsey say that flip damages the industry's credibility on cannabis safety more broadly.
The tension reflects a fundamental split in the industry. Licensed operators invested millions in state-legal operations with heavy tax burdens and strict regulations. They argue hemp products create unfair competition and lack safety testing. Hemp sellers counter that they're operating legally under federal law and serving consumers in states without adult-use programs.
The Market Reality
Hemp-derived THC products have exploded since 2018, creating a multi-billion dollar market. Delta-8 THC, THCA flower, and other cannabinoids are now available in states where traditional cannabis remains illegal. The products appeal to consumers who want legal access without dispensary prices or medical cards.
Several states have already moved to restrict or ban these products. Texas recently banned THCA flower. Minnesota imposed testing requirements. Other states are considering similar measures, often with support from licensed cannabis operators.
But Smith and Lindsey argue this approach is counterproductive. Rather than seeking bans, they suggest licensed operators should push for reasonable regulations that level the playing field while keeping products available.
What's at Stake
The debate over hemp THC products is playing out as federal rescheduling efforts continue and more states consider legalization. How the industry handles this issue could shape public perception of cannabis policy for years.
If licensed operators successfully ban hemp products by arguing they're unsafe, they hand ammunition to prohibition advocates who can point to the industry's own safety concerns. If hemp products remain widely available without incident, it could undermine arguments for strict state licensing systems.
Smith and Lindsey's perspective carries weight given their roles in building the modern cannabis policy movement. Both spent years at MPP, which helped pass some of the earliest medical and adult-use laws. Their warning suggests the hemp debate is about more than market share—it's about the long-term viability of cannabis reform.
The industry faces a choice: compete with hemp products on quality and service, or seek government bans that contradict years of safety messaging. Smith and Lindsey are clear about which path they think makes sense.
This article is based on original reporting by www.marijuanamoment.net.
